Neos Therapeutics, Inc. (NEOS) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for NEOS in the last 30 days. The most recent was published Oct 16, 2023.
Latest news
25 items- FDAFDA Approval for COTEMPLA XR-ODT issued to NEOS THERAPS INCSubmission status for NEOS THERAPS INC's drug COTEMPLA XR-ODT (SUPPL-12) with active ingredient METHYLPHENIDATE has changed to 'Approval' on 10/13/2023. Application Category: NDA, Application Number: 205489, Application Classification: Labeling
- FDAFDA Approval for COTEMPLA XR-ODT issued to NEOS THERAPS INCSubmission status for NEOS THERAPS INC's drug COTEMPLA XR-ODT (SUPPL-7) with active ingredient METHYLPHENIDATE has changed to 'Approval' on 06/25/2021. Application Category: NDA, Application Number: 205489, Application Classification: Labeling
- SECSEC Form EFFECT filed by Neos Therapeutics, Inc.EFFECT - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form EFFECT filed by Neos Therapeutics, Inc.EFFECT - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form EFFECT filed by Neos Therapeutics, Inc.EFFECT - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form EFFECT filed by Neos Therapeutics, Inc.EFFECT - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form 8-K filed by Neos Therapeutics, Inc.8-K - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form 425 filed by Neos Therapeutics, Inc.425 - Neos Therapeutics, Inc. (0001467652) (Subject)
- INSIDERSEC Form 4: M John Limongelli disposed to the issuer $0 worth of Common Stock (83,015 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: Jr. A. James Robinson disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: W. Gerald Mclaughlin disposed to the issuer $0 worth of Common Stock (270,171 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: Beth Hecht disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: P. John Schmid disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: Bryant Fong disposed to the issuer $0 worth of Common Stock (24,953 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: M Linda Szyper disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: J Gregory Robitaille disposed to the issuer $0 worth of Common Stock (79,130 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: L Alan Heller disposed to the issuer $0 worth of Common Stock (446,819 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- INSIDERSEC Form 4: I Richard Eisenstadt disposed to the issuer $0 worth of Common Stock (126,245 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
- SECSEC Form S-8 POS filed by Neos Therapeutics, Inc.S-8 POS - Neos Therapeutics, Inc. (0001467652) (Filer)
NEOS FAQ
6 questionsWhat is the latest news on NEOS?
Quantisnow has not tracked any new filings, ratings or press releases for NEOS in the last 30 days. The most recent wire item was published on October 16, 2023.Where does NEOS stock trade?
Neos Therapeutics, Inc. (NEOS) is listed on NASDAQ.What sector and industry is NEOS in?
Neos Therapeutics, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.When did Neos Therapeutics, Inc. go public?
Neos Therapeutics, Inc. (NEOS) completed its IPO in 2015.What companies are similar to NEOS?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare NEOS side-by-side with any of them on Quantisnow.How can I track NEOS on Quantisnow?
Quantisnow aggregates Neos Therapeutics, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NEOS to receive live email and push alerts on every new disclosure.